Date	Name	Title	Type	Shares Traded	Price Range
Feb 8, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	33,800	9.94 - 10.28
Feb 8, 2008	topper james n	Director	Buy	33,800	9.94 - 10.28
Feb 11, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	5,700	9.93 - 10.16
Feb 11, 2008	topper james n	Director	Buy	5,700	9.93 - 10.16
Feb 4, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	25,352	9.92 - 10.31
Feb 4, 2008	topper james n	Director	Buy	25,352	9.92 - 10.31
Mar 6, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	22,146	9.90 - 10.18
Feb 1, 2008	licholai gregory p	Officer	Sell	10,000	9.90
Mar 6, 2008	topper james n	Director	Buy	22,146	9.90 - 10.18
Feb 21, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	5,500	9.86 - 10.50
Feb 21, 2008	topper james n	Director	Buy	5,500	9.86 - 10.50
Oct 31, 2008	bloch stephen m	Director	Automatic Sell	3,000	9.85
Mar 1, 2008	dentzer james e	Officer	Disposition (Non Open Market)	220	9.85
Mar 4, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	9,000	9.85 - 10.12
Mar 4, 2008	topper james n	Director	Buy	9,000	9.85 - 10.12
Feb 28, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	2,038	9.84 - 9.96
Feb 28, 2008	topper james n	Director	Buy	2,038	9.84 - 9.96
Sep 1, 2009	dentzer james e	Officer	Disposition (Non Open Market)	220	9.83
Mar 3, 2008	topper james n	Director	Buy	18,426	9.83 - 9825.00
Mar 3, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	18,426	9.83 - 10.00
Showing 221-240 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.